List of Tables
Table 1. Global Drugs for Treating Metabolic Disorders Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Drugs for Treating Metabolic Disorders Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Drugs for Treating Metabolic Disorders Market Competitive Situation by Manufacturers in 2023
Table 4. Global Drugs for Treating Metabolic Disorders Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Drugs for Treating Metabolic Disorders Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Drugs for Treating Metabolic Disorders Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Drugs for Treating Metabolic Disorders Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Drugs for Treating Metabolic Disorders Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Drugs for Treating Metabolic Disorders, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drugs for Treating Metabolic Disorders, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drugs for Treating Metabolic Disorders, Product Type & Application
Table 12. Global Key Manufacturers of Drugs for Treating Metabolic Disorders, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs for Treating Metabolic Disorders by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Treating Metabolic Disorders as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs for Treating Metabolic Disorders Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Drugs for Treating Metabolic Disorders Sales by Region (2019-2024) & (K Units)
Table 18. Global Drugs for Treating Metabolic Disorders Sales Market Share by Region (2019-2024)
Table 19. Global Drugs for Treating Metabolic Disorders Sales by Region (2025-2030) & (K Units)
Table 20. Global Drugs for Treating Metabolic Disorders Sales Market Share by Region (2025-2030)
Table 21. Global Drugs for Treating Metabolic Disorders Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Drugs for Treating Metabolic Disorders Revenue Market Share by Region (2019-2024)
Table 23. Global Drugs for Treating Metabolic Disorders Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Drugs for Treating Metabolic Disorders Revenue Market Share by Region (2025-2030)
Table 25. North America Drugs for Treating Metabolic Disorders Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Drugs for Treating Metabolic Disorders Sales by Country (2019-2024) & (K Units)
Table 27. North America Drugs for Treating Metabolic Disorders Sales by Country (2025-2030) & (K Units)
Table 28. North America Drugs for Treating Metabolic Disorders Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Drugs for Treating Metabolic Disorders Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Drugs for Treating Metabolic Disorders Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Drugs for Treating Metabolic Disorders Sales by Country (2019-2024) & (K Units)
Table 32. Europe Drugs for Treating Metabolic Disorders Sales by Country (2025-2030) & (K Units)
Table 33. Europe Drugs for Treating Metabolic Disorders Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Drugs for Treating Metabolic Disorders Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Drugs for Treating Metabolic Disorders Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Drugs for Treating Metabolic Disorders Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Drugs for Treating Metabolic Disorders Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Drugs for Treating Metabolic Disorders Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Drugs for Treating Metabolic Disorders Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drugs for Treating Metabolic Disorders Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Drugs for Treating Metabolic Disorders Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Drugs for Treating Metabolic Disorders Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Drugs for Treating Metabolic Disorders Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drugs for Treating Metabolic Disorders Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drugs for Treating Metabolic Disorders Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Drugs for Treating Metabolic Disorders Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Drugs for Treating Metabolic Disorders Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Drugs for Treating Metabolic Disorders Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Drugs for Treating Metabolic Disorders Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Drugs for Treating Metabolic Disorders Sales (K Units) by Type (2019-2024)
Table 51. Global Drugs for Treating Metabolic Disorders Sales (K Units) by Type (2025-2030)
Table 52. Global Drugs for Treating Metabolic Disorders Sales Market Share by Type (2019-2024)
Table 53. Global Drugs for Treating Metabolic Disorders Sales Market Share by Type (2025-2030)
Table 54. Global Drugs for Treating Metabolic Disorders Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Drugs for Treating Metabolic Disorders Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Drugs for Treating Metabolic Disorders Revenue Market Share by Type (2019-2024)
Table 57. Global Drugs for Treating Metabolic Disorders Revenue Market Share by Type (2025-2030)
Table 58. Global Drugs for Treating Metabolic Disorders Price (US$/Unit) by Type (2019-2024)
Table 59. Global Drugs for Treating Metabolic Disorders Price (US$/Unit) by Type (2025-2030)
Table 60. Global Drugs for Treating Metabolic Disorders Sales (K Units) by Application (2019-2024)
Table 61. Global Drugs for Treating Metabolic Disorders Sales (K Units) by Application (2025-2030)
Table 62. Global Drugs for Treating Metabolic Disorders Sales Market Share by Application (2019-2024)
Table 63. Global Drugs for Treating Metabolic Disorders Sales Market Share by Application (2025-2030)
Table 64. Global Drugs for Treating Metabolic Disorders Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Drugs for Treating Metabolic Disorders Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Drugs for Treating Metabolic Disorders Revenue Market Share by Application (2019-2024)
Table 67. Global Drugs for Treating Metabolic Disorders Revenue Market Share by Application (2025-2030)
Table 68. Global Drugs for Treating Metabolic Disorders Price (US$/Unit) by Application (2019-2024)
Table 69. Global Drugs for Treating Metabolic Disorders Price (US$/Unit) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Drugs for Treating Metabolic Disorders Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Drugs for Treating Metabolic Disorders Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Drugs for Treating Metabolic Disorders Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Drugs for Treating Metabolic Disorders Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Eli Lilly and Company Corporation Information
Table 81. Eli Lilly and Company Description and Business Overview
Table 82. Eli Lilly and Company Drugs for Treating Metabolic Disorders Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lilly and Company Drugs for Treating Metabolic Disorders Product
Table 84. Eli Lilly and Company Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Drugs for Treating Metabolic Disorders Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AstraZeneca Drugs for Treating Metabolic Disorders Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Drugs for Treating Metabolic Disorders Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Merck Drugs for Treating Metabolic Disorders Product
Table 94. Merck Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Drugs for Treating Metabolic Disorders Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Johnson & Johnson Drugs for Treating Metabolic Disorders Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Boehringer Ingelheim Corporation Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Drugs for Treating Metabolic Disorders Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Boehringer Ingelheim Drugs for Treating Metabolic Disorders Product
Table 104. Boehringer Ingelheim Recent Developments/Updates
Table 105. Gilead Sciences Corporation Information
Table 106. Gilead Sciences Description and Business Overview
Table 107. Gilead Sciences Drugs for Treating Metabolic Disorders Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Gilead Sciences Drugs for Treating Metabolic Disorders Product
Table 109. Gilead Sciences Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Drugs for Treating Metabolic Disorders Distributors List
Table 113. Drugs for Treating Metabolic Disorders Customers List
Table 114. Drugs for Treating Metabolic Disorders Market Trends
Table 115. Drugs for Treating Metabolic Disorders Market Drivers
Table 116. Drugs for Treating Metabolic Disorders Market Challenges
Table 117. Drugs for Treating Metabolic Disorders Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drugs for Treating Metabolic Disorders
Figure 2. Global Drugs for Treating Metabolic Disorders Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drugs for Treating Metabolic Disorders Market Share by Type in 2023 & 2030
Figure 4. Antidiabetic Drugs Product Picture
Figure 5. Antihypertensive Drugs Product Picture
Figure 6. Hypolipidemic Drugs Product Picture
Figure 7. Others Product Picture
Figure 8. Global Drugs for Treating Metabolic Disorders Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Drugs for Treating Metabolic Disorders Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Pharmacy
Figure 12. Global Drugs for Treating Metabolic Disorders Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Drugs for Treating Metabolic Disorders Market Size (2019-2030) & (US$ Million)
Figure 14. Global Drugs for Treating Metabolic Disorders Sales (2019-2030) & (K Units)
Figure 15. Global Drugs for Treating Metabolic Disorders Average Price (US$/Unit) & (2019-2030)
Figure 16. Drugs for Treating Metabolic Disorders Report Years Considered
Figure 17. Drugs for Treating Metabolic Disorders Sales Share by Manufacturers in 2023
Figure 18. Global Drugs for Treating Metabolic Disorders Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Drugs for Treating Metabolic Disorders Players: Market Share by Revenue in 2023
Figure 20. Drugs for Treating Metabolic Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Drugs for Treating Metabolic Disorders Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Drugs for Treating Metabolic Disorders Sales Market Share by Country (2019-2030)
Figure 23. North America Drugs for Treating Metabolic Disorders Revenue Market Share by Country (2019-2030)
Figure 24. United States Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Drugs for Treating Metabolic Disorders Sales Market Share by Country (2019-2030)
Figure 27. Europe Drugs for Treating Metabolic Disorders Revenue Market Share by Country (2019-2030)
Figure 28. Germany Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Drugs for Treating Metabolic Disorders Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Drugs for Treating Metabolic Disorders Revenue Market Share by Region (2019-2030)
Figure 35. China Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Drugs for Treating Metabolic Disorders Sales Market Share by Country (2019-2030)
Figure 43. Latin America Drugs for Treating Metabolic Disorders Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Drugs for Treating Metabolic Disorders Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Drugs for Treating Metabolic Disorders Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Drugs for Treating Metabolic Disorders Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Drugs for Treating Metabolic Disorders by Type (2019-2030)
Figure 53. Global Revenue Market Share of Drugs for Treating Metabolic Disorders by Type (2019-2030)
Figure 54. Global Drugs for Treating Metabolic Disorders Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Drugs for Treating Metabolic Disorders by Application (2019-2030)
Figure 56. Global Revenue Market Share of Drugs for Treating Metabolic Disorders by Application (2019-2030)
Figure 57. Global Drugs for Treating Metabolic Disorders Price (US$/Unit) by Application (2019-2030)
Figure 58. Drugs for Treating Metabolic Disorders Value Chain
Figure 59. Drugs for Treating Metabolic Disorders Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed